Ensysce Biosciences (ENSCW) Stock Price, News & Analysis
Company Description
Ensysce Biosciences (OTC Link: ENSCW) is classified in the biotechnology industry within the Healthcare sector.
ENSCW has declined 96.2% over the past year. Shares last traded at $0.0008.
For FY2025, Ensysce Biosciences reported revenue of $5.1M with net income of -$10.2M and diluted earnings per share of $-3.98. The company operates at a net profit margin of -200.9%.
This page collects what Stock Titan holds for ENSCW, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Ensysce Biosciences (ENSCW) stock last closed at $0.0008. Over the past 12 months, the stock has lost 96.2%.
ENSCW Rankings
Latest News
Ensysce Biosciences has 10 recent news articles. Of the recent coverage, 1 article coincided with positive price movement and 8 with negative movement. Key topics include management, clinical trial, partnership. View all ENSCW news →
SEC Filings
Ensysce Biosciences has filed 5 recent SEC filings, including 2 Form 8-K, 1 Form S-3, 1 Form 10-Q, 1 Form 10-K. The most recent filing was submitted on June 4, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all ENSCW SEC filings →
Financial Highlights
Ensysce Biosciences generated $5.1M in revenue in FY2025, operating income reached -$10.2M (-202.1% operating margin), and net income was -$10.2M, reflecting a -200.9% net profit margin. Diluted earnings per share stood at $-3.98. The company generated -$7.8M in operating cash flow. With a current ratio of 1.59, the balance sheet reflects a strong liquidity position.
Upcoming Events
Short Interest History
Short interest in Ensysce Biosciences (ENSCW) currently stands at 58.6 thousand shares.
Days to Cover History
Days to cover for Ensysce Biosciences (ENSCW) currently stands at 2.5 days, down 68.6% from the previous period. This days-to-cover ratio represents a balanced liquidity scenario for short positions. The days to cover has decreased 20.8% over the past year, suggesting improved liquidity for short covering. The ratio has shown significant volatility over the period, ranging from 1.0 to 1000.0 days.
ENSCW Company Profile & Sector Positioning
Ensysce Biosciences (ENSCW) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing ENSCW often look at related companies in the same sector, including Virpax Pharmaceuticals Inc (VRPX), POOLBEG PHARMA PLC (POLBF), Defence Therapeu (DTCFF), Oncotelic Therapeutics Inc (OTLC), and Preveceutical (PRVCF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate ENSCW's relative position within its industry.